CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021
Cash flows from operating activities:
Net income	$ 480,693	$ 476,604
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	30,929	21,949
Deferred income taxes	(20,836)	9,219
Depreciation	54,306	52,760
Amortization of intangibles	44,799	45,166
Acquired in-process research and development and other non-cash items	10,003	0
Change in operating assets and liabilities:
(Increase) decrease in accounts receivable	(39,098)	23,472
Increase in inventories	(113,211)	(93,878)
Increase in other current assets	(6,861)	(9,123)
Increase in other assets	(3,881)	(6,116)
Decrease in accounts payable and other current liabilities	(4,952)	(4,768)
Increase in deferred revenue and customer advances	47,060	71,889
Decrease in other liabilities	(65,999)	(57,838)
Net cash provided by operating activities	412,952	529,336
Cash flows from investing activities:
Additions to property, plant, equipment and software capitalization	(113,737)	(116,614)
Proceeds from (investments in) equity investments, net	8,903	(867)
Payments for intellectual property licenses	(7,535)	(7,000)
Purchases of investments	(11,407)	(241,230)
Maturities and sales of investments	77,993	117,283
Net cash used in investing activities	(45,783)	(248,428)
Cash flows from financing activities:
Proceeds from debt issuances	165,000	510,000
Payments on debt	(135,000)	(250,000)
Payments of debt issuance costs	0	(8,537)
Proceeds from stock plans	36,136	55,000
Purchases of treasury shares	(477,167)	(492,695)
Proceeds from derivative contracts	12,844	2,325
Net cash used in financing activities	(398,187)	(183,907)
Effect of exchange rate changes on cash and cash equivalents	(26,579)	(8,994)
(Decrease) increase in cash and cash equivalents	(57,597)	88,007
Cash and cash equivalents at beginning of period	501,234	436,695
Cash and cash equivalents at end of period	$ 443,637	$ 524,702